CHICAGO, June 7, 2021 /PRNewswire/ — According to the new market research report “Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 6.7 billion by 2026 from USD 5.4 billion in 2020, at a CAGR of 3.8% during the forecast period.
Browse in-depth TOC on “Lung Cancer Surgery Market”
182 – Tables
27 – Figures
163 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222
The market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence of lung cancer, rising trend of smoking tobacco, rising geriatric population, the increasing emphasis on early diagnosis & treatment of cancers, and availability of reimbursement. However, the high cost of lung cancer diagnosis & surgical treatments is expected to restrain this markets growth during the forecast period. The increasing adoption of refurbished imaging systems
The powered surgical equipment segment accounted for the largest share of the lung cancer surgery market, by surgical instruments segment, in 2020
Based on surgical instruments, the market is segmented into powered surgical equipment and hand Instruments. In 2020, the powered surgical…
